|
25 Jul 2019 |
Proteostasis Therapeutics Initiates Dosing in Global Phase 2 Study in Cystic Fibrosis
|
|
25 Jul 2019 |
Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome
|
|
25 Jul 2019 |
Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227
|
|
25 Jul 2019 |
Bristol-Myers Squibb Announces CheckMate -227 Part 1a Meets Co-Primary Endpoint of Overall Survival
|
|
25 Jul 2019 |
Epizyme Announces FDA Filing Acceptance of New Drug Application and Priority Review for Tazemetostat for the Treatment of Epithelioid Sarcoma
|
|
24 Jul 2019 |
Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707
|
|
24 Jul 2019 |
Merck Announces Presentation of Phase 2b Results for Investigational HIV-1 Therapy Islatravir (MK-8591) at IAS 2019
|
|
24 Jul 2019 |
ViiV Healthcare presents GEMINI 1 & 2 studies through Week 96 showing 2-drug regimen of dolutegravir plus lamivudine continues to demonstrate high efficacy rates and no cases of treatment emergent resistance
|
|
24 Jul 2019 |
Oyster Point Pharma Announces Enrollment of First Subject in Phase 3 Clinical Trial of Nasal Spray for Dry Eye Disease
|
|
24 Jul 2019 |
Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation
|
|
24 Jul 2019 |
Gilead Announces Latest Data in Ongoing HIV Cure Research Program
|
|
24 Jul 2019 |
Ligand Acquires Ab Initio Biotherapeutics, an Antigen-Discovery Company
|
|
24 Jul 2019 |
FDA Approves Samsung Bioepis' HADLIMA™ (adalimumab-bwwd)
|
|
24 Jul 2019 |
FDA Approves Pfizer’s Biosimilar, RUXIENCE™ (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions
|
|
23 Jul 2019 |
Marinus Pharmaceuticals Announces Data from Magnolia and Amaryllis Phase 2 Studies in Women with Postpartum Depression
|
|
23 Jul 2019 |
Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and Positive Results from Bioequivalence Study
|
|
23 Jul 2019 |
Novel Drug Being Developed for HIV Prevention and Cancer Indications Demonstrates Best-in-Class Potency
|
|
23 Jul 2019 |
IVERIC bio Announces Successful Advancement of LCA10 Minigene Program and Expansion of Orphan Gene Therapy Portfolio with USH2A-Related Inherited Retinal Diseases Program
|
|
23 Jul 2019 |
Oncolytics Biotech(R) Announces Preliminary AWARE-1 Trial Data Demonstrating Viral Replication and Promotion of Inflammation Following Systemic Administration of Pelareorep When Combined with Tecentriq(R)
|
|
23 Jul 2019 |
Merck Presents Early Evidence on Extended Delivery of Investigational Anti-HIV-1 Agent Islatravir (MK-8591) via Subdermal Implant
|
